Store
Women’s Health Diagnostic Markets: Global Outlook and Forecast to 2030
Publication Date: July 14, 2025
Tags: Breast Imaging, Cancer, Diagnostics, Fertility, Genetic Diseases, In Vitro Diagnostics (IVD), Infectious Diseases, Mammography, Oncology and Cancer, POC, Point-of-Care (POC) Diagnostics, Point-of-Care (POC) Testing, Pregnancy
Pages: 210
SKU: 25-072KA
Kalorama Information’s Women’s Health Diagnostic Markets: Global Outlook and Forecast to 2030 offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women’s health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift—with women living longer than men—healthcare systems are under increasing pressure to recognize and address sex-based differences in disease risk, screening, and treatment. Diagnostics are at the core of this transformation, offering the ability to deliver personalized and timely interventions across a woman’s life span.
This in-depth report forecasts global market revenues for diagnostic tests and systems through 2030, providing regional segmentation and trend analysis across a broad spectrum of diagnostic categories relevant to female health. The study encompasses both established and emerging technologies used in the detection, screening, and monitoring of conditions unique to, or highly prevalent among, women. Market sizing reflects product and system sales, including associated services such as instrument installation and software support.
Key diagnostic sectors covered in the report include:
- Breast and Reproductive Health Imaging: Mammography, CADe/CADx, OB/GYN ultrasound, and breast ultrasound imaging.
- Prenatal and Carrier Screening: Non-invasive prenatal testing (NIPT), carrier screening, and maternal-fetal diagnostics.
- Infectious and Sexually Transmitted Diseases: HPV diagnostics, TORCH immunoassays, and molecular urinary tract infection (UTI) testing.
- Fertility and Pregnancy Testing: Lab-based and POC tests for ovulation, fertility hormones, and pregnancy status.
- Cancer and Chronic Disease Monitoring: Pap tests, ovarian cancer biomarkers, and female-specific autoimmune immunoassays.
- Bone Health and Preventive Diagnostics: Bone densitometry testing and colposcopy systems for early cancer detection.
Each chapter explores the scientific foundations and technological innovations driving growth in its respective category while addressing challenges such as regulatory shifts, reimbursement, market access, and product differentiation. The report draws on interviews with industry experts, input from clinical labs, and extensive primary and secondary research to inform market forecasts and trend assessments.
A diverse group of diagnostic players—ranging from dominant multinationals to nimble niche firms—are profiled in each category. Companies covered include BD, GE Healthcare, Hologic, Roche, Siemens Healthineers, and Thermo Fisher, among others. These firms are actively shaping the future of women’s diagnostics through innovation in biomarkers, automation, digital imaging, and home-based testing.
At a time when diagnostic testing influences more than 70% of medical decisions, this report positions women’s health diagnostics not only as a growing market but also as a critical component of precision medicine. The insights contained herein are essential for stakeholders focused on expanding access, improving clinical outcomes, and investing in the next generation of diagnostic solutions tailored to women’s evolving health needs.
About Kalorama Information
Chapter 1: Executive Summary
Overview
Scope and Methodology
Market Overview and Potential
- Figure 1-1: World Markets for Key Women’s Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]
- Table 1-1: World Markets for Key Women’s Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]
Chapter 2: Introduction
Female Health: Room for Improvement
Perspective on Women’s Health
Women and Men Develop Some Diseases Differently
Pain
The Heart
The Brain
Emotions
Bone Structure
Alcohol
Drug Side Effects
Smoking
Fertility
STIs and HIV
Autoimmune Disease
Cancer
Leading Female Cancers
Musculoskeletal Health
Congenital Abnormalities
Urinary Tract Infections (UTIs)
Key Trends and Issues in Women’s Health Diagnostics
Ovarian Cancer Diagnostics and Biomarkers
HPV Testing
Broader Carrier Screening and NIPT
Multiplex and Molecular Testing for UTIs
Imaging and AI
Pregnancy and Ovulation
Autoimmune Laboratory Immunoassays
Chapter 3: Mammography
Introduction
Transition to Digital
Economics of Routine Screening
Digital Breast Tomosynthesis (DBT or 3D Mammography)
Mammography Market
- Table 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 3-2: World Mammography Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 3-3: World Mammography Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Computer-Aided Detection/Diagnosis (CADe/CADx)
- Table 3-2: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 3-4: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 3-5: World CADe/CADx Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 3-6: World CADe/CADx Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Artificial Intelligence Adoption in Breast Imaging
Key Trends in AI-Driven CAD
Trends
Regulatory Changes
Competitive Landscape
Fujifilm Holdings Corp.
GE HealthCare
Hologic
Siemens Healthineers
Chapter 4: Ultrasound
Introduction
- Table 4-1: Key Applications for Medical Ultrasound
Obstetrics and Gynecology
Breast Imaging
Market Trends
Obstetric and Gynecological Ultrasound Trends
- Table 4-2: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 4-1: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 4-2: World Ultrasound OB/GYN Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 4-3: World Ultrasound OB/GYN Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Breast Imaging Market
- Table 4-3: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 4-4: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 4-5: World Ultrasound Breast Imaging Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 4-6: World Ultrasound Breast Imaging Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
GE HealthCare
Hologic
Philips
Siemens Healthineers
Chapter 5: Prenatal and Carrier Screening
Introduction
NIPT
Advances in Genetics Bring New Challenges
Carrier Screening
Test Adoption Trends
Inherited Diseases
Inflammatory Bowel Disease (IBD) and Crohn’s Disease
Autism Spectrum Disorder (ASD)
Alzheimer’s Disease (AD)
Cardiovascular Disease (CVD)
Psychiatric Disorders
M&A, Partnerships
NIPT and Carrier Screening Markets
- Table 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 5-2: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 5-3: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Agilent
Illumina
Qiagen
Revvity
Thermo Fisher Scientific
Chapter 6: HPV Testing
Introduction
Overview
HPV Infection
Infection in Females
High-Risk Types and Cervical Cancer
HPV Testing
HPV IVD Test Market
- Table 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 6-2: World Female HPV IVD Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 6-3: World Female HPV IVD Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
HPV Testing and Global Screening Programs
Competitive Landscape
BD (Becton, Dickinson and Company)
Hologic
QIAGEN
Roche
Chapter 7: Pregnancy and Ovulation
Introduction
Perspective on Testing
Digital Testing
Lab Testing
Trends
Market
POC Pregnancy and Fertility Test Market
- Table 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 7-2: World POC Pregnancy Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 7-3: World POC Pregnancy Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
- Table 7-2: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 7-4: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 7-5: World Lab-Based Fertility Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 7-6: World Lab-Based Fertility Immunoassay Market, Share by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Products
TORCH Testing
- Table 7-3: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 7-7: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 7-8: World Lab-Based TORCH Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 7-9: World Lab-Based TORCH Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Market Participants
NowDiagnostics Inc.
Salignostics
Sekisui
Acon
Major Companies
Abbott
Beckman Coulter (Danaher)
bioMérieux
Church & Dwight
Roche
Siemens Healthineers
Chapter 8: Pap Smears
Introduction
Testing for Cervical Cancer
Trends
Pap Test Market
- Table 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 8-2: World IVD Traditional Pap Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 8-3: World IVD Traditional Pap Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
BD (Becton Dickinson)
Hologic
Chapter 9: Autoimmune Disease
Introduction
Genetic Factors
Impact on Female Patients
Recent Developments
Female Autoimmune Lab-Based Immunoassay Market
- Table 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 9-2: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World] ($ million)
- Figure 9-3: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Bio-Rad
Euroimmun (Revvity)
Thermo Fisher Scientific
Chapter 10: Bone Density Testing
Introduction
Alarming Rise in Osteoporosis
Propelling the Need for Measurement
Trends in DEXA and Competing Technologies
DEXA: The Gold Standard
Emerging Trends and Accessibility
Bone Densitometry Market
- Table 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 10-2: World Bone Densitometry for Female Testing Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 10-3: World Bone Densitometry for Female Testing Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
DMS Imaging (European Medical Solutions)
GE HealthCare
Hologic
Chapter 11: Colposcopy
Introduction
Cervical Cancer Screening and Diagnosis
Trends
Colposcopy Systems Market
- Table 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 11-2: World Colposcopy Systems Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 11-3: World Colposcopy Systems Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Apgar Danmark A/S
CooperSurgical
Olympus
Chapter 12: Urinary Tract Infections
Introduction
Leading Cause of Morbidity and Death
Impact
Trends
Technological Advances Outpace Clinical Guidelines
Next-Generation Sequencing (NGS)
Multiplex PCR, qPCR
UTI Molecular Test Market
- Table 12-1: World Molecular UTI Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 12-1: World Molecular UTI Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 12-2: World Molecular UTI Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 12-3: World Molecular UTI Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Potential in Small Companies
Company Highlights
BioGX
Camtech
PathogenDx
Randox Laboratories
RayBiotech
Thermo Fisher Scientific
Chapter 13: Ovarian Cancer
Introduction
Types of Ovarian Cancer
CA-125
Trends
Multivariate Index Assays and Genomic Tests
Ovarian Cancer Biomarker Market
- Table 13-1: World Ovarian Cancer Biomarkers Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 13-1: World Ovarian Cancer Biomarkers Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
- Figure 13-2: World Ovarian Cancer Biomarkers Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
- Figure 13-3: World Ovarian Cancer Biomarkers Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Company Highlights
Abbott
Fujirebio
Illumina
Roche
Thermo Fisher Scientific
Related products
Cell and Gene Therapy Market and Deals Analysis, 2023
May 22, 2023
Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals tracks deal-making and market opportunities in cell and gene therapy, providing specific details of 1000+ deals from 2022-2023. With a staggering $40 billion in CGT deals in 2022 alone, understanding the market dynamics and key…
Price range: $4,000.00 through $6,000.00
At-Home Diagnostic Testing Markets and Trends, 2023
June 6, 2023
Kalorama Information’s report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023, delves into the expanding world of at-home and home collection tests. The at-home in vitro diagnostic (IVD) testing market comprises tests that can be purchased over the counter or online, where patients collect specimens and receive results within…
Price range: $4,000.00 through $6,000.00
Histology and Cytology IVD Market Update, 2024
May 21, 2024
Histology and cytology have long been essential components of pathological laboratories, offering critical insights into cells, tissues, and organs. Through histopathological examinations, a variety of diseases, including cancer, can be accurately diagnosed. Physicians rely heavily on pathological information to determine treatment plans and prognoses.
Histology and Cytology IVD Market Update, 2024 provides an in-depth competitive analysis…
Price range: $5,000.00 through $7,875.00
